Evidence map›Paper›PMID 34684136›Full record

Observational studyMedicina (Kaunas, Lithuania)2021

Clostridium Difficile and COVID-19: General Data, Ribotype, Clinical Form, Treatment-Our Experience from the Largest Infectious Diseases Hospital in Western Romania.

Adelina Raluca Marinescu, Ruxandra Laza, Virgil Filaret Musta, Talida Georgiana Cut, Raluca Dumache, Anca Tudor, Mirela Porosnicu, Voichita Elena Lazureanu, Monica Licker

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Medicina (Kaunas, Lithuania), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Antibiotic Usage and Healthcare-AssociatedAntibiotics (Basel, Switzerland) · 2025
    Article
  2. Review
  3. Microorganisms · 2024
    Article
  4. Future microbiology · 2024
    Observational
  5. COVID-19 andAntibiotics (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Microorganisms · 2022
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Adelina Raluca MarinescuDepartment XIII, Discipline of Infectious Diseases, University of Medicine and Pharmacy "Victor Babes", 300041 Timisoara, Romania.
Ruxandra LazaDepartment XIII, Discipline of Infectious Diseases, University of Medicine and Pharmacy "Victor Babes", 300041 Timisoara, Romania.
Virgil Filaret MustaDepartment XIII, Discipline of Infectious Diseases, University of Medicine and Pharmacy "Victor Babes", 300041 Timisoara, Romania.
Talida Georgiana CutDepartment XIII, Discipline of Infectious Diseases, University of Medicine and Pharmacy "Victor Babes", 300041 Timisoara, Romania.ORCID 0000-0002-6567-4407
Raluca DumacheCenter for Ethics in Human Genetic Identifications, University of Medicine and Pharmacy "Victor Babes", 300041 Timisoara, Romania.
Anca TudorDepartment III, Discipline of Informatics and Medical Biostatistics, University of Medicine and Pharmacy "Victor Babes", 300041 Timisoara, Romania.ORCID 0000-0001-9630-4727
Mirela PorosnicuClinical Hospital of Infectious Diseases and Pneumophtisiology "Doctor Victor Babes" Timisoara, 300310 Timisoara, Romania.
Voichita Elena LazureanuDepartment XIII, Discipline of Infectious Diseases, University of Medicine and Pharmacy "Victor Babes", 300041 Timisoara, Romania.
Monica LickerDepartment XIV, Discipline of Microbiology, University of Medicine and Pharmacy "Victor Babes", 300041 Timisoara, Romania.ORCID 0000-0002-9245-5883
Victor Babeș University of Medicine and Pharmacy Timișoara · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clostridioides difficileCommunicable DiseasesCOVID-19Cross InfectionAnti-Bacterial AgentsHospitalsHumansPandemicsRetrospective StudiesRibotypingRomaniaSARS-CoV-2Anti-Bacterial Agentsantibiotic usageclostridium difficile infection (CDI)COVID-19 pandemicoutcomeribotyperisk factors

Identifiers

PMID34684136
PMCPMC8539017
OpenAlexW3205677373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.